Home » Topics » Disease categories and therapies » Cancer

Cancer
RSS

U.S. academic team takes a novel approach to treating prostate cancer

Nov. 24, 1999

New taxane analogue from Bristol-Myers Squibb now in phase I testing

Nov. 24, 1999

Combination A6 and tamoxifen effective in rat breast tumor

Nov. 24, 1999

SuperGen and Stehlin Foundation extend research and licensing agreement

Nov. 24, 1999

New SERM from SRI and Taiho holds excellent clinical potential

Nov. 23, 1999

Agouron initiates pilot phase II trial of prinomastat as treatment of glioblastoma multiforme

Nov. 23, 1999

Patent for paclitaxel formulations issued to NaPro BioTherapeutics

Nov. 23, 1999

Diatide's radiolabeled somatostatin analogue exerts potent antitumor effects in mice

Nov. 23, 1999

Pharma Mar isolates marine compound with potent and selective activity against solid tumors

Nov. 23, 1999

Preclinical profile of tyrosine kinase inhibitor supports initiation of clinical testing

Nov. 23, 1999

Popular Stories

Today's news in brief
BioWorld
IL-22 and TL1A, a robust couple for diagnosing hidradenitis suppurativa
BioWorld Science
Hidradenitis suppurativa (HS) is a chronic inflammatory skin disease with strong association with psoriasis and inflammatory bowel disease (IBD). While some...
TL1A is overexpressed in hidradenitis suppurativa
BioWorld Science
Despite the availability of advanced therapeutic options, about 40%-50% of patients with hidradenitis suppurativa do not achieve significant improvement in...
Inhibiting the NLRP3 inflammasome for cognitive impairment, stroke
BioWorld Science
Vascular cognitive impairment and dementia (VCID) and cerebral small vessel disease are among the leading causes of dementia, where inflammation is known to play...
VST Bio’s VB-001 is neuroprotector after stroke
BioWorld Science
At the recent International Stroke Conference, researchers from VST Bio Corp. and Yale University presented preclinical data regarding VB-001, a monoclonal...